Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2316-2327

  Yan, Jing ^a,b   Meng, Xiaomei ^a   Wancket, Lyn M ^c   Lintner, Katherine ^a   Nelin, Leif D ^a   Chen, Bernadette ^a   Francis, Kevin P ^d   Smith, Charles V ^e   Rogers, Lynette K ^a   Liu, Yusen ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c OHIO STATE UNIVERSITY   (United States)

^d Caliper Life Sciences   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE REDUCTASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CATALYSIS; CELL DEATH; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE STORM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EX VIVO STUDY; HEXONE MONOPHOSPHATE SHUNT; HISTOPATHOLOGY; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MORTALITY; MOUSE; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EXTRACELLULAR SPACE; GLUTATHIONE REDUCTASE; HUMANS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; NEUTROPHILS; OXIDATIVE STRESS; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84863172698     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102683     Document Type: Article

References (61)

1. Klebanoff, S. J., and R. A. Clark. 1978. The Neutrophil: Function and Clinical Disorders. North-Holland Publishing, Amsterdam.
2. Balija, T. M., and S. F. Lowry. 2011. Lipopolysaccharide and sepsis-associated myocardial dysfunction. Curr. Opin. Infect. Dis. 24: 248-253.
3. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182. (Pubitemid 43290987)
4. Lambeth, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4: 181-189. (Pubitemid 38339084)
5. Babior, B. M. 2004. NADPH oxidase. Curr. Opin. Immunol. 16: 42-47. (Pubitemid 38198116)
6. Tardif, M., M. J. Rabiet, T. Christophe, M. D. Milcent, and F. Boulay. 1998. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate. J. Immunol. 161: 6885-6895. (Pubitemid 28562234)
7. Kennedy, A. D., and F. R. DeLeo. 2008. PI3K and NADPH oxidase: a class act. Blood 112: 4788-4789.
8. phox is a physiological signal in NADPH oxidase activation. EMBO J. 25: 4468-4478.
9. Knaus, U. G., P. G. Heyworth, T. Evans, J. T. Curnutte, and G. M. Bokoch. 1991. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254: 1512-1515. (Pubitemid 21917492)
10. Abo, A., E. Pick, A. Hall, N. Totty, C. G. Teahan, and A. W. Segal. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353: 668-670. (Pubitemid 21912587)
11. Chen, J., H. Tang, N. Hay, J. Xu, and R. D. Ye. 2010. Akt isoforms differentially regulate neutrophil functions. Blood 115: 4237-4246.
12. phox and rapid activation of nicotinamide adenine dinucleotide phosphate oxidase. J. Immunol. 179: 7720-7728.
13. Inanami, O., J. L. Johnson, J. K. McAdara, J. E. Benna, L. R. Faust, P. E. Newburger, and B. M. Babior. 1998. Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J. Biol. Chem. 273: 9539-9543. (Pubitemid 28183039)
14. PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc. Natl. Acad. Sci. USA 100: 5130-5135.
15. Heyworth, P. G., A. R. Cross, and J. T. Curnutte. 2003. Chronic granulomatous disease. Curr. Opin. Immunol. 15: 578-584. (Pubitemid 37130200)
16. Brinkmann, V., and A. Zychlinsky. 2007. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5: 577-582. (Pubitemid 47074113)
17. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y.Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241. (Pubitemid 46143263)
18. Wartha, F., and B. Henriques-Normark. 2008. ETosis: a novel cell death pathway. Sci. Signal. 1: pe25.
19. Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, and A. Zychlinsky. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535. (Pubitemid 38314426)
20. Pilsczek, F. H., D. Salina, K. K. Poon, C. Fahey, B. G. Yipp, C. D. Sibley, S. M. Robbins, F. H. Green, M. G. Surette, M. Sugai, et al. 2010. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185: 7413-7425.
21. Bianchi, M., M. J. Niemiec, U. Siler, C. F. Urban, and J. Reichenbach. 2011. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J. Allergy Clin. Immunol. 127: 1243-1252, e7.
22. Lin, A. M., C. J. Rubin, R. Khandpur, J. Y. Wang, M. Riblett, S. Yalavarthi, E. C. Villanueva, P. Shah, M. J. Kaplan, and A. T. Bruce. 2011. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187: 490-500.
23. Reed, P. W. 1969. Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes. J. Biol. Chem. 244: 2459-2464.
24. Strauss, R. R., B. B. Paul, A. A. Jacobs, and A. J. Sbarra. 1969. The role of the phagocyte in host-parasite interactions. XIX. Leukocytic glutathione reductase and its involvement in phagocytosis. Arch. Biochem. Biophys. 135: 265-271.
25. Cohen, H. J., E. H. Tape, J. Novak, M. E. Chovaniec, P. Liegey, and J. C. Whitin. 1987. The role of glutathione reductase in maintaining human granulocyte function and sensitivity to exogenous H2O2. Blood 69: 493-500. (Pubitemid 17022019)
26. Loos, H., D. Roos, R. Weening, and J. Houwerzijl. 1976. Familial deficiency of glutathione reductase in human blood cells. Blood 48: 53-62.
27. Roos, D., R. S. Weening, A. A. Voetman, M. L. van Schaik, A. A. Bot, L. J. Meerhof, and J. A. Loos. 1979. Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood 53: 851-866. (Pubitemid 9178658)
28. a1Neu mice does not cause haemolytic anaemia. Genet. Res. 73: 1-5.
29. Rogers, L. K., T. Tamura, B. J. Rogers, S. E. Welty, T. N. Hansen, and C. V. Smith. 2004. Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout. Toxicol. Sci. 82: 367-373. (Pubitemid 39600063)
30. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203: 131-140. (Pubitemid 43139652)
31. Wang, X., X. Meng, J. R. Kuhlman, L. D. Nelin, K. K. Nicol, B. K. English, and Y. Liu. 2007. Knockout of Mkp-1 enhances the host inflammatory responses to Gram-positive bacteria. J. Immunol. 178: 5312-5320. (Pubitemid 46595317)
32. Frazier, W. J., X. Wang, L. M. Wancket, X. A. Li, X. Meng, L. D. Nelin, A. C. Cato, and Y. Liu. 2009. Increased inflammation, impaired bacterial clearance, and metabolic disruption after Gram-negative sepsis in Mkp-1-deficient mice. J. Immunol. 183: 7411-7419.
33. Georgel, P., K. Crozat, X. Lauth, E. Makrantonaki, H. Seltmann, S. Sovath, K. Hoebe, X. Du, S. Rutschmann, Z. Jiang, et al. 2005. A Toll-like receptor 2- responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect. Immun. 73: 4512-4521. (Pubitemid 41105605)
34. Sharma, P. K., E. Engels, W. Van Oeveren, R. J. Ploeg, C. van Henny der Mei, H. J. Busscher, G. M. Van Dam, and G. Rakhorst. 2010. Spatiotemporal progression of localized bacterial peritonitis before and after open abdomen lavage monitored by in vivo bioluminescent imaging. Surgery 147: 89-97.
35. Boxio, R., C. Bossenmeyer-Pourié, N. Steinckwich, C. Dournon, and O. Nüsse. 2004. Mouse bone marrow contains large numbers of functionally competent neutrophils. J. Leukoc. Biol. 75: 604-611. (Pubitemid 38405651)
36. Gross, S., S. T. Gammon, B. L. Moss, D. Rauch, J. Harding, J. W. Heinecke, L. Ratner, and D. Piwnica-Worms. 2009. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 15: 455-461.
37. Kehrer, J. P. 1983. The effect of BCNU (carmustine) on tissue glutathione reductase activity. Toxicol. Lett. 17: 63-68. (Pubitemid 13054054)
38. Pachman, L. M., P. Jayanetra, and R. M. Rothberg. 1973. Rheumatoid sera and soluble complexes: nitroblue tetrazolium dye test and hexose monophosphate shunt activation. Pediatrics 52: 823-830.
39. Li, J., M. Gorospe, D. Hutter, J. Barnes, S. M. Keyse, and Y. Liu. 2001. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol. Cell. Biol. 21: 8213-8224. (Pubitemid 33051810)
40. Chen, P., D. Hutter, X. Yang, M. Gorospe, R. J. Davis, and Y. Liu. 2001. Discordance between the binding affinity of mitogen-activated protein kinase sub-family members for MAP kinase phosphatase-2 and their ability to catalytically activate the phosphatase. J. Biol. Chem. 276: 29440-29449.
41. Edwards, J. L., J. Q. Shao, K. A. Ault, and M. A. Apicella. 2000. Neisseria gonorrhoeae elicits membrane ruffling and cytoskeletal rearrangements upon infection of primary human endocervical and ectocervical cells. Infect. Immun. 68: 5354-5363.
42. Chen, P., J. Li, J. Barnes, G. C. Kokkonen, J. C. Lee, and Y. Liu. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169: 6408-6416. (Pubitemid 36903490)
43. Thrasher, A. J., N. H. Keep, F. Wientjes, and A. W. Segal. 1994. Chronic granulomatous disease. Biochim. Biophys. Acta 1227: 1-24. (Pubitemid 24320379)
44. Sriskandan, S., and D. M. Altmann. 2008. The immunology of sepsis. J. Pathol. 214: 211-223. (Pubitemid 351160158)
45. Klebanoff, S. J. 2005. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77: 598-625. (Pubitemid 40628741)
46. Takei, H., A. Araki, H. Watanabe, A. Ichinose, and F. Sendo. 1996. Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis. J. Leukoc. Biol. 59: 229-240. (Pubitemid 26098707)
47. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10: 427-439.
48. Koháryová, M., and M. Kolárová. 2008. Oxidative stress and thioredoxin system. Gen. Physiol. Biophys. 27: 71-84.
49. Dalle-Donne, I., R. Rossi, G. Colombo, D. Giustarini, and A. Milzani. 2009. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem. Sci. 34: 85-96.
50. Rokutan, K., J. A. Thomas, and R. B. Johnston, Jr. 1991. Phagocytosis and stimulation of the respiratory burst by phorbol diester initiate S-thiolation of specific proteins in macrophages. J. Immunol. 147: 260-264.
51. Seres, T., V. Ravichandran, T. Moriguchi, K. Rokutan, J. A. Thomas, and R. B. Johnston, Jr. 1996. Protein S-thiolation and dethiolation during the respiratory burst in human monocytes: a reversible post-translational modification with potential for buffering the effects of oxidant stress. J. Immunol. 156: 1973-1980. (Pubitemid 26069333)
52. Rinna, A., M. Torres, and H. J. Forman. 2006. Stimulation of the alveolar macrophage respiratory burst by ADP causes selective glutathionylation of protein tyrosine phosphatase 1B. Free Radic. Biol. Med. 41: 86-91. (Pubitemid 43866455)
53. Lim, S. Y., M. J. Raftery, J. Goyette, and C. L. Geczy. 2010. S-glutathionylation regulates inflammatory activities of S100A9. J. Biol. Chem. 285: 14377-14388.
54. Kuhns, D. B., W. G. Alvord, T. Heller, J. J. Feld, K. M. Pike, B. E. Marciano, G. Uzel, S. S. DeRavin, D. A. Priel, B. P. Soule, et al. 2010. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363: 2600-2610.
55. Underhill, D. M., and A. Ozinsky. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20: 825-852. (Pubitemid 34293441)
56. Greenberg, S., and S. Grinstein. 2002. Phagocytosis and innate immunity. Curr. Opin. Immunol. 14: 136-145. (Pubitemid 34085118)
57. Selvaraj, R. J., and A. J. Sbarra. 1966. Relationship of glycolytic and oxidative metabolism to particle entry and destruction in phagocytosing cells. Nature 211: 1272-1276.
58. Deponte, M., S. Urig, L. D. Arscott, K. Fritz-Wolf, R. Réau, C. Herold-Mende, S. Koncarevic, M. Meyer, E. Davioud-Charvet, D. P. Ballou, et al. 2005. Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase. J. Biol. Chem. 280: 20628-20637. (Pubitemid 40776766)
59. Becker, K., C. Herold-Mende, J. J. Park, G. Lowe, and R. H. Schirmer. 2001. Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2″-terpyridine) platinum(II) complexes: possible implications for a novel antitumor strategy. J. Med. Chem. 44: 2784-2792. (Pubitemid 32879719)
60. Sarma, G. N., S. N. Savvides, K. Becker, M. Schirmer, R. H. Schirmer, and P. A. Karplus. 2003. Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J. Mol. Biol. 328: 893-907. (Pubitemid 36506894)
61. Davioud-Charvet, E., S. Delarue, C. Biot, B. Schwöbel, C. C. Boehme, A. Müssigbrodt, L. Maes, C. Sergheraert, P. Grellier, R. H. Schirmer, and K. Becker. 2001. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J. Med. Chem. 44: 4268-4276. (Pubitemid 33095332)